117 related articles for article (PubMed ID: 6184565)
1. Clinical pharmacokinetics of calcium channel antagonists.
McAllister RG
J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S340-5. PubMed ID: 6184565
[TBL] [Abstract][Full Text] [Related]
2. Calcium-channel blocking agents.
Leonard RG; Talbert RL
Clin Pharm; 1982; 1(1):17-33. PubMed ID: 6764159
[TBL] [Abstract][Full Text] [Related]
3. [Clinical pharmacology of calcium antagonists].
Lauterburg BH
Schweiz Med Wochenschr; 1987 Mar; 117(13):496-501. PubMed ID: 3576161
[TBL] [Abstract][Full Text] [Related]
4. [Clinical pharmacology of calcium inhibitors].
Singlas E; Martre H; Taburet AM
Arch Mal Coeur Vaiss; 1985 Nov; 78 Spec No():15-22. PubMed ID: 3937500
[TBL] [Abstract][Full Text] [Related]
5. Calcium antagonists. Pharmacokinetic properties.
Kates RE
Drugs; 1983 Feb; 25(2):113-24. PubMed ID: 6339196
[TBL] [Abstract][Full Text] [Related]
6. Clinical pharmacokinetics of verapamil, nifedipine and diltiazem.
Echizen H; Eichelbaum M
Clin Pharmacokinet; 1986; 11(6):425-49. PubMed ID: 3542336
[TBL] [Abstract][Full Text] [Related]
7. Update on calcium-channel blocking agents.
Talbert RL; Bussey HI
Clin Pharm; 1983; 2(5):403-16. PubMed ID: 6354566
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of calcium-entry blockers.
McAllister RG; Hamann SR; Blouin RA
Am J Cardiol; 1985 Jan; 55(3):30B-40B. PubMed ID: 3881917
[TBL] [Abstract][Full Text] [Related]
9. Clinical pharmacology of calcium antagonists: a critical review.
Eichelbaum M; Echizen H
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S963-7. PubMed ID: 6085385
[TBL] [Abstract][Full Text] [Related]
10. [Interaction between calcium antagonists and digoxin].
Christensen C
Ugeskr Laeger; 1991 Apr; 153(17):1180-4. PubMed ID: 2028527
[TBL] [Abstract][Full Text] [Related]
11. [Principles of the pharmacokinetics and pharmacodynamics of calcium antagonists].
Rameis H
Wien Med Wochenschr; 1993; 143(19-20):490-500. PubMed ID: 8135031
[TBL] [Abstract][Full Text] [Related]
12. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
13. Clinical differentiation of nifedipine and other calcium antagonists.
Ebner F; Donath M; Rämsch KD
Arq Bras Cardiol; 1984 Jul; 43(1):5-12. PubMed ID: 6395839
[No Abstract] [Full Text] [Related]
14. Clinical pharmacological aspects of calcium antagonists and their therapeutic role in hypertension.
Reid JL; Meredith PA; Pasanisi F
J Cardiovasc Pharmacol; 1985; 7 Suppl 4():S18-20. PubMed ID: 2412006
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of diltiazem and other calcium entry blockers.
Hermann P; Morselli PL
Acta Pharmacol Toxicol (Copenh); 1985; 57 Suppl 2():10-20. PubMed ID: 3904330
[TBL] [Abstract][Full Text] [Related]
16. Lercanidipine: short plasma half-life, long duration of action and high cholesterol tolerance. Updated molecular model to rationalize its pharmacokinetic properties.
Herbette LG; Vecchiarelli M; Sartani A; Leonardi A
Blood Press Suppl; 1998; 2():10-7. PubMed ID: 9850437
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of nitrendipine in patients with renal failure: comparison to normal subjects.
Aronoff GR
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S974-6. PubMed ID: 6085387
[TBL] [Abstract][Full Text] [Related]
18. Effects of hemodynamic changes on the elimination kinetics of verapamil and nifedipine.
Hamann SR; Blouin RA; Chang SL; Kaltenborn KE; Tan TG; McAllister RG
J Pharmacol Exp Ther; 1984 Nov; 231(2):301-5. PubMed ID: 6491984
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacokinetics of calcium antagonists].
Richard MO
Therapie; 1993; 48 Spec No():651-7. PubMed ID: 8091350
[TBL] [Abstract][Full Text] [Related]
20. Calcium channel blockers.
Dipalma JR
Am Fam Physician; 1983 Feb; 27(2):283-5. PubMed ID: 6829383
[No Abstract] [Full Text] [Related]
[Next] [New Search]
